JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A4447 2,3-DCPE hydrochloride

Target: Apoptosis Inducers

Summary: Bcl-XL protein expression downregulator

<30.06 mg/mL
A4448 Actinomycin D
15 Citation

Summary: RNA polymerase inhibitor

≥62.75 mg/mL
A4452 Mitomycin C
3 Citation

Summary: Inhibits DNA synthesis,antibiotic and antitumor agent

insoluble in H2O; insoluble in EtOH; ≥16.7 mg/mL
A4453 NSC 687852 (b-AP15)

Target: Deubiquitinating enzymes (DUBs)

Summary: 19S regulatory particle Inhibitor

insoluble in EtOH; insoluble in H2O; ≥20.95 mg/mL
A8236 Regorafenib
4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A8804 AMG232
2 Citation

Target: p53-MDM2 interaction

Summary: p53-MDM2 inhibitor, novel

Soluble in DMSO
B3232 Z-IETD-FMK
12 Citation

Target: Caspases

Summary: Caspase-8 inhibitor

≥32.73 mg/mL
B4881 UMI-77
1 Citation

Target: Mcl-1

Summary: Mcl-1 inhibitor, novel

≥23.4 mg/mL
B5846 Radotinib(IY-5511)

Target: PDGFR|Bcr-Abl

Summary: Bcr-Abl tyrosine kinase inhibitor

≥13.73 mg/mL
B5978 BDA-366

Target: Bcl-2

Summary: Selective antagonist of BCL2 BH4 domain

≥50.4 mg/mL